Supercomputing reveals the genetic code of cancer
Cancer researchers are now using one of the world's fastest computers to detect which parts of the genetic code may cause bowel and prostate cancer.
Interview with Principal Investigator Rolf Skotheim in the research magazine Apollon.
May help tailor treatment
Cancer researchers must use one of the world’s fastest computers to detect which versions of genes are only found in cancer cells. Every form of cancer, even every tumour, has its own distinct variants.
“This charting may help tailor the treatment to each patient,” says Associate Professor Rolf Skotheim, Principal Investigator in the K.G. Jebsen Colorectal Cancer Research Centre.
His research group is working to identify the genes that cause bowel and prostate cancer, which are both common diseases. There are 4,000 new cases of bowel cancer in Norway every year. Only six out of ten patients survive the first five years. Prostate cancer affects 5,000 Norwegians every year. Nine out of ten survive.
Read the entire article in the research magazine Apollon: Supercomputing reveals the genetic code of cancer
Latest publicationsSveen et al. 2019. Predictive modeling in colorectal cancer: time to move beyond consensus molecular subtypes. Ann. Oncol. 30(11): 1682-1685 Miranda et al. 2019. Cancer stemness, intratumoral heterogeneity, and immune response across cancers. PNAS 116(18): 9020-9029 Burocziova et al. 2019. Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon. Cell Death. Dis. 10(11): 818
Eilertsen et al. 2019. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer. Cancer Lett. [Epub ahead of print] Lopes et al. 2019. Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2. Lab. Invest. [Epub ahead of print] All publications